Outerwall (OUTR) PT Cut to $57 at Piper Jaffray on Lower Outlook; Maintains 'Overweight' on Valuation

Go back to Outerwall (OUTR) PT Cut to $57 at Piper Jaffray on Lower Outlook; Maintains 'Overweight' on Valuation

Outerwall (OUTR) PT Cut to $61.50 at Roth Capital with Redbox Weak as Expected

December 8, 2015 8:54 AM EST

Roth Capital maintained a Buy rating on Outerwall Inc. (NASDAQ: OUTR), and cut the price target to $61.50 (from $80.00), following weak Redbox performance. OUTR released updated guidance for FY15, which reflects lower than expected RB revenue in 4Q, in addition to announcing an expected write-off certain... More

Outerwall (OUTR) PT Cut to $59 at Wedbush Amid Weak Redbox Results

December 8, 2015 7:36 AM EST

Wedbush maintained an Outperform rating on Outerwall Inc. (NASDAQ: OUTR), and cut the price target to $59.00 (from $100.00), following weak rentals for its Redbox division. Management increased kiosk inventory in Q4 in order to improve customer engagement, hoping to drive higher volumes by improving quantity... More

UPDATE: Outerwall's (OUTR) Decline Seen as 'Overreaction'; B. Riley Upgrades to Buy

December 8, 2015 7:00 AM EST

(Updated - December 8, 2015 9:28 AM EST)

B. Riley upgraded Outerwall Inc. (NASDAQ: OUTR) from Neutral to Buy with a price target of $58.00. Shares decline after Outerwall reported disappointed guidance. However, analyst Eric Wold doesn't think its Q4 guide-down indicates accelerating Redbox decline, and he called the stock's post-market drop an overreaction.

"We had already been modeling a rather... More

After-Hours Stock Movers 12/07: (TXMD) (ORIG) (CLLS) Higher; (OUTR) (UNFI) (CMG) Lower (more...)

December 7, 2015 5:49 PM EST

TherapeuticsMD, Inc. (NYSE: TXMD) 35% HIGHER; announced positive top-line results from its pivotal Phase 3 Rejoice Trial of TX-004HR, an investigational, applicator-free vaginal estradiol softgel, for the treatment of moderate to severe dyspareunia (vaginal pain during sexual intercourse), a symptom of vulvar and vaginal atrophy (VVA) due to menopause. VVA is a chronic condition affecting nearly half of postmenopausal women in the United States that can significantly impair their quality of life.

Outerwall... More

Market Wrap: Lower Crude Prices Pressures Markets; Keurig to be Acquired; Nike, LeBron Enter Lifetime Deal

December 7, 2015 5:25 PM EST

Market wrap for December 7th

End of the Day: S&P 500 down 14.6 to 2,077.07; Dow Jones down 117.1 to 17,730.51; Nasdaq down 40.5 to 5,101.81

Market Brief: Falling oil prices pressured the energy segment and broader markets today.

Keurig Green Mountain entered a takeover agreement.

Nike signed NBA superstar LeBron James for the long haul.

Carl Icahn moved to acquire Pep Boys.

Newell Rubbermaid and Jarden are said to be in merger talks.

PIMCO tapped top talent for its new Global Advisory Board.

Gold... More

Outerwall (OUTR) Sinks 29% as Trading Resumes

December 7, 2015 4:47 PM EST

Outerwall (NASDAQ: OUTR) resume trading and is down 29% after lowering FY 2015 outlook.

... More

Outerwall (OUTR) Trims FY15 Outlook; Announced Resignation of Redbox President Horak

December 7, 2015 4:15 PM EST

Outerwall Inc. (Nasdaq: OUTR) provided an update on its financial expectations for the full year 2015. The revised outlook reflects lower Redbox segment revenue than expected for the fourth quarter of 2015 based on preliminary results through the end of November and expectations for December, as well as the expected write-off of certain capitalized assets associated with its SampleIt concept, which the company has decided to discontinue.

For the full year 2015, the company now expects:

Redbox revenue between $1.750 billion and $1.765 billion, compared with the prior range of $1.790 billion to $1.815 billion;Consolidated revenue... More

Outerwall (OUTR) trading halted with news pending

December 7, 2015 4:13 PM EST

Outerwall (NASDAQ: OUTR) trading halted with news pending.

... More